Jan Grunewald

Company: AstraZeneca

Job title: Associate Director

Seminars:

1:00 pm Workshop D: Refining the Next Antibody- Oligonucleotide Conjugates (AOC) & Delivery Chemistries 1:00 pm

Antibody-oligonucleotide conjugates (AOCs) represent a cutting-edge approach to improving targeted RNA therapeutics, offering enhanced precision in delivery, while overcoming key barriers such as biodistribution and cellular uptake. This workshop will focus on the latest advancements in AOC design, with a particular emphasis on brain shuttle strategies and delivery chemistry to optimize therapeutic outcomes for neurological…Read more

day: Pre-Conference Workshop Day - Track B P2